News bites
Restructure at Merck KGaA
Merck KGaA has announced measures to reduce costs and increase efficiency to ensure the long-term success of its business
model. The measures are expected to result in workforce reductions across all businesses and regions. The measures will be
implemented in two phases.
http://PharmTech.com/merckrestructure
GSK recall
GSK recently recalled 394230 bottles of its antihypertensive drug DynaCirc CR (isradipine) controlled-release tablets. The
lots were recalled due to concerns regarding the level of cGMP compliance and procedural controls related to line clearance
during the packing process at a US-based facility of Novartis Consumer Health, where the product was made.
http://PharmTech.com/gskrecall
FDA's DTC guidance
The FDA has released a draft guidance for direct-to-consumer (DTC) television advertisements in the US. Companies will have
to submit their TV ads for FDA review at least 45 days before dissemination. After reviewing, the FDA can recommend changes
to protect consumers or to be more consistent with prescribing information.
http://PharmTech.com/TVads
Japanese vaccine venture
GlaxoSmithKline and Daiichi Sankyo have formed a joint venture hey claim will create the biggest vaccines company in Japan.
The joint venture will seek to improve access to vaccinations in Japan, as well as introduce new vaccines and create better
and more convenient combination vaccines. The new company will be called Japan Vaccine Co., Ltd.
http://PharmTech.com/JPvaccines
|
